Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000747

Drug Information
NameHydroflumethiazide    
Synonyms2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide; KBio2_006521; CID3647; MLS000028516; Diurometon; Di-adenil; Spectrum_000905; 7-Sulfamyl-6-trifluoromethyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; C07763; EINECS 205-173-8; Rodiuran; Metforylthiazidin; Enjit; Hidroalogen; Hidroflumetiazida; Hydrenox; Hydroflumethiazidum [INN-Latin]; SPBio_001139; SPBio_001966; Elodrine; AC1L1GEH; AC1Q4JYO; Metflorylthiazidine; H8760_SIGMA; CPD000058284; Olmagran; SPECTRUM1500341; Prestwick1_000013; HFZ; 7-Sulfamoyl-6-trifluoromethyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; Saluron (TN); UNII-501CFL162R; H8760_FLUKA; 4-27-00-08035 (Beilstein Handbook Reference); KBio2_001385; MolPort-001-771-232; 6-(Trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 2H-1,2, 4-Benzothiadiazine-7-sulfonamide, 3, 4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide; 3, 4-Dihydro-6-trifluorom; Saluron; LS-40451; Vergonil; Prestwick3_000013; 6-Trifluoromethyl-3,4-dihydro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; Idroflumetiazide [DCIT]; Rontyl; IDI1_000512; 3,4-Dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; WLN: T66 BSWM EM DHJ HXFFF ISZW; Hydol; NSC 44627; ethyl-2H-1,2, 4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 3, 4-Dihydro-6-trifluoromethyl-7-sulfamoylbenzo-1,2,4-thiadiazine 1, 1-dioxide; 3,4-Dihydro-7-sulfamoyl-6-trifluoromethyl-2H-1,2, 4-benzothi; 6-Trifluoromethyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide; 7-Sulfamyl-6-trifluoromethyl-3,4-dihydro-1,2,4-benzothiadiazine 1, 1-dioxide; Prestwick0_000013; HMS1568C07; Spectrum2_001010; SR-01000003094-2; Glomerulin; KBioSS_001385; KBio2_003953; DivK1c_000512; CHEMBL1763; SAM002703134; NCGC00016401-01; HMS501J14; Hydroflumethizide; NINDS_000512; 6-Trifluoromethyl-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide; Hydroflumethiazide [INN:BAN:JAN]; NCGC00016401-02; Robezon; 3,4-Dihydro-7-sulfamoyl-6-trifluoromethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; Elodrin; Methforylthiazidine; HSDB 3340; Metforylthiadiazin; HMS1920F05; 1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1; Hydroflumethiazidum; adiazine 1,1-dioxide; 6-Trifluoromethyl-3, 4-dihydro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; 6-Trifluoromethyl-7-sulfamoyl-3,4-dihydro-1,2, 4-benzothiadiazine-1,1-dioxide; 7-Sulfamoyl-6-tri; D00654; 3,4-Dihydro-6-trifluoromethyl-7-sulfamoylbenzo-1,2,4-thiadiazine 1,1-dioxide; KBioGR_000359; Spectrum5_000832; ZINC00897225; KBio1_000512; Bristurin; Idroflumetiazide; C8H8F3N3O4S2; CAS-135-09-1; 3,4-Dihydro-6-trifluoromethyl-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 3,4-Dihydro-7-sulfamyl-6-trifluoromethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; Hydroflumethiazide (JAN/USP/INN); 135-09-1; nchembio747-comp19; MLS001148090; Rivosil; KBio3_001360; BSPBio_002140; Di-ademil; Prestwick2_000013; NaClex; AR-1J2060; BRN 0342692; Hidroflumetiazida [INN-Spanish]; fluoromethyl-3, 4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; SB01887; NCGC00023353-04; Dihydroflumethiazide; Trifluoromethylhydrazide; BPBio1_000051; hydroflumethiazide; Prestwick_268; Trifluoromethylhydrothiazide; Flutizide; BSPBio_000045; SMR000058284; NSC44627; Hidroflumetiazid; Spectrum3_000460; component of Salutensin; NCGC00023353-03; Leodrine; Spandiuril; Hydroflumethazide; Finuret; Diucardin; Naciex (glaxo); Bristab; 6-(Trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; BRD-K36862742-001-05-8; AB00052016; DB00774; HMS2091L13; Sisuril; Spectrum4_000010; Dihydroflumethazide; Diuredemina    
IndicationEdema associated with congestive heart failureApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassDiuretics    
CAS NumberCAS 135-09-1
FormularC8H8F3N3O4S2    
PubChem Compound IDCID 3647.    
PubChem Substance IDSID 9965.    
SuperDrug ATC IDC03AA02;    
SuperDrug CAS ID000135091;    
TargetSolute carrier family 12 member 1Blocker[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 088850 To Reference
Ref 2DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. Epub 2007 Nov 29. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543